Form 4: Jazz Pharmaceuticals Executive Mary Elizabeth Henderson Reports Acquisition of Ordinary Shares

Mary Elizabeth Henderson, SVP of Technical Operations at Jazz Pharmaceuticals, reports the acquisition of ordinary shares through restricted stock units.

Summary

• Mary Elizabeth Henderson, SVP, Technical Operations at Jazz Pharmaceuticals, reported changes in beneficial ownership on March 3, 2025.
• The report details the acquisition of 5,392 ordinary shares and 3,852 ordinary shares through restricted stock units on February 27, 2025, at a price of $0.00.
• Following these transactions, Henderson directly owns 23,775 ordinary shares.
• The restricted stock units are granted under the company's 2011 Equity Incentive Plan.
• 5,392 units vest in equal annual installments over four years from March 5, 2025.
• 3,852 units will vest in full on June 30, 2026.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of shares by an executive is generally viewed favorably, indicating confidence in the company's prospects. The vesting schedules are standard and don't raise any concerns.

Positives

• The acquisition of shares by an executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules of the restricted stock units suggest a continued commitment from the executive.

Industry Context

Executive stock ownership is a common practice in the pharmaceutical industry to align management's interests with those of shareholders.

Comparison to Industry Standards

• Stock grants to executives are a standard component of compensation packages in publicly traded companies, including pharmaceutical firms like Amgen, Pfizer, and Johnson & Johnson.
• The vesting schedules described are typical for restricted stock units, often spanning several years to incentivize long-term performance.

Stakeholder Impact

• The acquisition of shares by an executive can positively influence shareholder sentiment.
• Employees may view this as a positive sign of company stability and growth potential.

Key Dates